Skip to content

Gaze Contingent Feedback for Anxiety Disorders in Children

Gaze-Contingent Music Reward Treatment for Anxiety Disorders in Children: A Case Series

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03171363
Enrollment
12
Registered
2017-05-31
Start date
2017-04-01
Completion date
2018-04-01
Last updated
2018-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety Disorders

Keywords

Attention bias modification treatment, Anxiety disorders, Attention training

Brief summary

The purpose of this study is to determine whether giving gaze-contingent feedback is an effective attention modification procedure, helping in the treatment of anxiety disorders in children.

Detailed description

Attention biases in threat processing have been assigned a prominent role in the etiology and maintenance of anxiety disorders. The purpose of this study is to determine whether giving gaze-contingent feedback is an effective treatment for anxiety disorders in clinically anxious 6-10 year-olds children. Participants will be assessed using clinical interviews and parent- and self-rated questionnaires before and after eight training sessions. Outcome measures will be anxiety symptoms and depression as measured by gold standard questionnaires as well as structured clinical interviews with children and their parents. Attentional threat bias and Attentional control will also be measured to explore potential mediators of ABMT's effect on anxiety.

Interventions

BEHAVIORALGaze-contingent feedback

Participants will receive gaze-contingent feedback according to their viewing patterns

Sponsors

Tel Aviv University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
6 Years to 10 Years
Healthy volunteers
No

Inclusion criteria

* Primary diagnosis of GAD, SOP, or SAD. * Co-morbid attention deficit hyperactivity disorder (ADHD) or depressive disorders must be treated with medication and stable. * Tics or impulse control problems must be treated with medication, stable and cause minimal or no impairment.

Exclusion criteria

To be excluded youth must: * meet diagnostic criteria for Organic Mental Disorders, Psychotic Disorders, Pervasive Developmental Disorders, or Mental Retardation. * show high likelihood of hurting themselves or others. * have not been living with a primary caregiver who is legally able to give consent for the child's participation. * be a victim of previously undisclosed abuse requiring investigation or ongoing supervision. * be involved currently in another psycho-social treatment. * have a serious vision problem that is not corrected with prescription lenses. * have a physical disability that interferes with their ability to click a mouse button rapidly and repeatedly.

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline in anxiety symptoms - the Pediatric Anxiety Rating (PARS)Post treatment (1 week after treatment completion)The PARS assesses global anxiety severity across different anxiety disorders in children

Secondary

MeasureTime frameDescription
Change from baseline in anxiety related emotional disorders symptoms - Child/Parent (the SCARED 41-item)Post treatment (1 week after treatment completion)The SCARED is a 41-item self and parent-report instrument designed to assess anxiety in children.

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026